Tags

Type your tag names separated by a space and hit enter

Estimating comparable English healthcare costs for multiple diseases and unrelated future costs for use in health and public health economic modelling.
PLoS One. 2018; 13(5):e0197257.Plos

Abstract

OBJECTIVES

Healthcare interventions, and particularly those in public health may affect multiple diseases and significantly prolong life. No consensus currently exists for how to estimate comparable healthcare costs across multiple diseases for use in health and public health cost-effectiveness models. We aim to describe a method for estimating comparable disease specific English healthcare costs as well as future healthcare costs from diseases unrelated to those modelled.

METHODS

We use routine national datasets including programme budgeting data and cost curves from NHS England to estimate annual per person costs for diseases included in the PRIMEtime model as well as age and sex specific costs due to unrelated diseases.

RESULTS

The 2013/14 annual cost to NHS England per prevalent case varied between £3,074 for pancreatic cancer and £314 for liver disease. Costs due to unrelated diseases increase with age except for a secondary peak at 30-34 years for women reflecting maternity resource use.

CONCLUSIONS

The methodology described allows health and public health economic modellers to estimate comparable English healthcare costs for multiple diseases. This facilitates the direct comparison of different health and public health interventions enabling better decision making.

Authors+Show Affiliations

Nuffield Department of Population Health, University of Oxford, Oxford, Oxfordshire, United Kingdom. The Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, Lebanon, New Hampshire, United States of America.Nuffield Department of Population Health, University of Oxford, Oxford, Oxfordshire, United Kingdom.Nuffield Department of Population Health, University of Oxford, Oxford, Oxfordshire, United Kingdom.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

29795586

Citation

Briggs, Adam D M., et al. "Estimating Comparable English Healthcare Costs for Multiple Diseases and Unrelated Future Costs for Use in Health and Public Health Economic Modelling." PloS One, vol. 13, no. 5, 2018, pp. e0197257.
Briggs ADM, Scarborough P, Wolstenholme J. Estimating comparable English healthcare costs for multiple diseases and unrelated future costs for use in health and public health economic modelling. PLoS ONE. 2018;13(5):e0197257.
Briggs, A. D. M., Scarborough, P., & Wolstenholme, J. (2018). Estimating comparable English healthcare costs for multiple diseases and unrelated future costs for use in health and public health economic modelling. PloS One, 13(5), e0197257. https://doi.org/10.1371/journal.pone.0197257
Briggs ADM, Scarborough P, Wolstenholme J. Estimating Comparable English Healthcare Costs for Multiple Diseases and Unrelated Future Costs for Use in Health and Public Health Economic Modelling. PLoS ONE. 2018;13(5):e0197257. PubMed PMID: 29795586.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Estimating comparable English healthcare costs for multiple diseases and unrelated future costs for use in health and public health economic modelling. AU - Briggs,Adam D M, AU - Scarborough,Peter, AU - Wolstenholme,Jane, Y1 - 2018/05/24/ PY - 2018/01/15/received PY - 2018/04/28/accepted PY - 2018/5/26/entrez PY - 2018/5/26/pubmed PY - 2018/12/12/medline SP - e0197257 EP - e0197257 JF - PloS one JO - PLoS ONE VL - 13 IS - 5 N2 - OBJECTIVES: Healthcare interventions, and particularly those in public health may affect multiple diseases and significantly prolong life. No consensus currently exists for how to estimate comparable healthcare costs across multiple diseases for use in health and public health cost-effectiveness models. We aim to describe a method for estimating comparable disease specific English healthcare costs as well as future healthcare costs from diseases unrelated to those modelled. METHODS: We use routine national datasets including programme budgeting data and cost curves from NHS England to estimate annual per person costs for diseases included in the PRIMEtime model as well as age and sex specific costs due to unrelated diseases. RESULTS: The 2013/14 annual cost to NHS England per prevalent case varied between £3,074 for pancreatic cancer and £314 for liver disease. Costs due to unrelated diseases increase with age except for a secondary peak at 30-34 years for women reflecting maternity resource use. CONCLUSIONS: The methodology described allows health and public health economic modellers to estimate comparable English healthcare costs for multiple diseases. This facilitates the direct comparison of different health and public health interventions enabling better decision making. SN - 1932-6203 UR - http://www.nlm.medscape.idmu.unboundmedicine.unboundmedicine.com/medline/citation/29795586/Estimating_comparable_English_healthcare_costs_for_multiple_diseases_and_unrelated_future_costs_for_use_in_health_and_public_health_economic_modelling_ L2 - http://dx.plos.org/10.1371/journal.pone.0197257 DB - PRIME DP - Unbound Medicine ER -